Opinion · 25 Jun 2026
Conference abstractPublished 3 Nov 2014
Perioperative NSAIDs may reduce early relapses in breast cancer: Perhaps transient systemic inflammation plays a role
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
While there have been important improvements in recent years, a general method to prevent relapses from early stage cancer is one of the most important unsolved problems in oncology. Author and his colleagues have been studying a bimodal pattern of hazard of relapse among early stage breast cancer patients that has been identified in multiple databases from US, Europe and Asia. In order to explain early relapse, they postulated that something happens at about the time of surgery to provoke sudden exits from dormant phases to active growth and then to detection. Most relapses in breast cancer are early. Recent data suggest an unexpected mechanism. A retrospective analysis of results from 327 consecutive breast cancer patients was conducted comparing various perioperative analgesics and anesthetics. A common NSAID analgesic used in surgery produced far superior disease-free survival in the first 5 years after surgery. The expected prominent early relapse events in months 9-18 are reduced 5-fold. If these observations hold up to further scrutiny, it could mean that the use of inexpensive and non-toxic anti-inflammatory agents at surgery might eliminate early relapses. Transient systemic inflammation accompanying surgery (identified by markers in serum) could facilitate angiogenesis of dormant micrometastases, proliferation of dormant single cells, and seeding of circulating tumor cells (perhaps in part released from bone marrow) resulting in early relapse and could have been effectively blocked by the perioperative anti-inflammatory agent.
Subjects
General & Internal MedicineAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Translational Medicine.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalTranslational Medicine
- SubjectGeneral & Internal Medicine
- BylineArticles whose byline prints “Michael Retsky”
